REsearching Covid-19 Outcomes in Diabetes (RECODE)

Active, not recruitingOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

October 22, 2024

Study Completion Date

December 31, 2025

Conditions
Covid19Diabetes
Trial Locations (1)

32804

AdventHealth Translational Research Institute, Orlando

All Listed Sponsors
lead

AdventHealth Translational Research Institute

OTHER